v3.26.3
STOCKHOLDERS’ EQUITY (Tables)
 9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
Schedule of Stock Option Activity
A summary of stock option activity as of September 30, 2026 is as follows:
(In thousands, except prices and years)Number of
options		Weighted-
average
exercise
price		Weighted- average remaining contractual life (years)Aggregate intrinsic value
Options outstanding at January 1, 2026
859 $18.38 3.77$135,938 
Granted (1)— — 
Exercised(377)15.82 
Forfeited and expired (2)— — 
Options outstanding at September 30, 2026
482 $20.36 3.44$59,481 
Options exercisable at September 30, 2026
482 $20.36 3.44$59,481 
________________
(1) There were no stock options granted during the three and nine months ended September 30, 2026.
(2) There was a nominal amount of forfeitures and expirations during the three and nine months ended September 30, 2026.
Schedule of Restricted Stock Unit Activity
A summary of RSU activity as of September 30, 2026 is as follows:
(In thousands, except prices)Restricted stock unitsWeighted-
average
grant-date fair value per share
Outstanding at January 1, 2026
1,406 $242.94 
Granted2,147 113.27 
Released(656)177.86 
Forfeited(259)206.98 
Outstanding at September 30, 2026
2,638 $157.07 
Schedule of Income Statement Location for Compensation Expense
Stock-based compensation expense is included in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income as shown in the following table:
Three Months Ended September 30,Nine Months Ended September 30,
(In thousands)2026202520262025
Cost of revenues$36 $28 $90 $72 
Research and development30,977 22,821 80,361 61,115 
Sales and marketing2,495 1,633 6,299 4,657 
General and administrative13,969 11,083 33,584 35,331 
Total$47,477 $35,565 $120,334 $101,175